
Directory
Discover detailed profiles of PoC companies.

FUST Lab Co., Ltd.
Focused Ultrasonic Technology for Nano Dispersion and PFAS-Free Wastewater Treatment

Specialization
Ultrasonic Nano Dispersion Advanced Wastewater Treatment

Keywords
Focused Ultrasonic
Microbubble Technology

Category
Environmental Technology Industrial Water Treatment

Technology Introduction
Technology / Item Overview
-
FUST Lab (Focused Ultrasonic Technology Lab) pioneers focused ultrasonic energy systems for nano dispersion, non-biodegradable wastewater treatment, and PFAS degradation.
-
The company’s proprietary CAVITOX System applies microbubble cavitation to achieve incineration-free and chemical-free decomposition of persistent organic pollutants.
-
Offers a clean, sustainable alternative to ozone, UV, or peroxide-based oxidation processes (AOPs) — achieving over 99% degradation efficiency for pharmaceuticals and PFAS.
-
Enables both industrial wastewater reuse and zero-emission treatment aligned with global ESG and carbon-neutral mandates.
Owned Technology / Applied Products
(1) Owned Technology
-
Focused Ultrasonic Technology (KRISS-originated): Cylindrical ultrasonic transducer focusing energy precisely at the center for uniform nano dispersion.
- Microbubble Cavitation Technology: Generates high-pressure (2,000 atm) implosions that destroy pollutant molecular bonds.
-
Advanced Oxidation Process (AOP) Enhancement: Optimized to break down non-biodegradable chemicals below 5 ppb, outperforming ozone, UV, and H₂O₂ systems.
-
Patents Registered / Granted:
-
Nano Dispersion Equipment & Process (KR + PCT)
-
Drug Delivery System using Focused Ultrasonic Technology
-
Non-biodegradable Material Degradation via Focused Ultrasound
-
Trademarks: DEBREX, CAVITOX
-
(2) Applied Products
-
CAVITOX System: Advanced microbubble oxidation device for PFAS and pharma wastewater.
-
DEBREX Platform: Ultrasonic nano dispersion solution for biomedical and nanomaterial industries.
-
Customized Ultrasonic Reactor Units: For industrial wastewater recycling and fine chemical applications.

Development Needs & Value Proposition
(1) Problem Definition / Development Background
-
Traditional wastewater systems (filtration, ozonation, UV) fail to remove persistent toxins like PFAS and generate toxic byproducts.
-
Incineration of industrial wastewater emits large amounts of CO₂ and increases treatment costs.
(2) Value Proposition / Solution
-
CAVITOX delivers a chemical-free, incineration-free treatment system, reducing carbon emissions and energy costs by over 70%.
-
Achieves 99.9%+ degradation for APIs (Telmisartan, Sitagliptin) and PFAS compounds (PFOA, PFOS, PFOB).
-
Enables industrial wastewater reuse, reducing dependence on external water supply.
-
Applicable across semiconductors, pharmaceuticals, coatings, and battery manufacturing sectors.
Competitiveness
-
Technology Origin: Derived from KRISS (Korea Research Institute of Standards and Science) with verified Proof of Concept (POC).
-
Performance:
-
Degrades non-biodegradable toxins below 5 ppb.
-
Maintains efficiency without chemical oxidizers or filters.
-
-
Sustainability:
-
Zero incineration, no secondary waste, and CO₂-free operation.
-
Operable with renewable energy, reducing indirect emissions.
-
-
Certification & Recognition:
-
ISO 9001 / 14001 / 45001 certified.
-
Pre-Series A funded by Blue Point Partners, Enlight Ventures, IBK, and KDB (USD 2.6M).
-

Company Performance & Business Status
Key References
-
Research Institution No. 1542 (approved by KRISS).
-
Developed CAVITOX, a market-ready solution with global patent protection and pilot PoC results.
-
Collaborations with Hitachi Hightech Korea, Swedish AZ R&D Group, and Ecoset Korea for field deployments.
-
Preparing large-scale demo installations (Frankfurt, Sept 2025) for global commercialization
Overseas Experience
(1) PoC Progress
-
Completed real wastewater PoC showing >99% degradation of APIs and PFAS.
-
Verified zebrafish embryo toxicity test — LC₅₀ safe range achieved.
-
Field-tested CAVITOX AOP system for pharmaceutical and semiconductor wastewater.
(2) Global Expansion
-
Japan (2024):
-
Patent filings in progress for nano dispersion and PFAS oxidation technologies.
-
-
Europe (2025):
-
MoU signed (Nov 2024) → Contract (Apr 2025) → Sales Launch (May 2025).
-
Frankfurt demo facility setup planned for Sept 2025.
-
-
Global Market Focus: Advanced oxidation, PFAS removal, and ESG-aligned wastewater recycling sectors.

